001     278997
005     20250713001342.0
024 7 _ |a 10.1002/alz.70252
|2 doi
024 7 _ |a pmid:40457754
|2 pmid
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
024 7 _ |a altmetric:177865356
|2 altmetric
037 _ _ |a DZNE-2025-00661
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kashani, Amir H
|b 0
245 _ _ |a Retinal optical coherence tomography angiography imaging in population studies for study of microvascular dysfunction in Alzheimer's disease and related dementias.
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1748955076_19908
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Widespread use of retinal optical coherence tomography angiography (OCT-A) imaging requires methodological and analytical consensus to ensure reproducible and accurate results in epidemiological studies on Alzheimer's disease and related dementias (ADRD).A consensus framework for assessment of fovea-centered 3 × 3-mm and 6 × 6-mm OCT-A image quality was developed, and reproducibility was reported. Agreement was assessed for overall image quality and image quality relevant for vessel density (VD) quantification and foveal avascular zone (FAZ) metrics. An analytic framework was also developed.Intergrader agreements for overall 3 × 3 mm image quality and quantitative assessment of VD and FAZ ranged between 71% and 87% (52 images). Intragrader agreements ranged between 82% and 93% (n = 27 images). Intergrader agreements were similar for 6 × 6-mm images. Three analytic scenarios were developed to account for bias that may result from image quality and ocular comorbidities.These recommendations provide a framework for working with OCT-A imaging in epidemiological studies on ADRD.Multicentric consensus on quality criteria for use of optical coherence tomography angiography (OCT-A) images in population studies was achieved, considering commonly used protocols acquired with commercially available devices (Heidelberg, Zeiss, and Topcon). Considerable inter- and intrarater agreement was achieved for assessment of OCT-A image quality. A framework for harmonized data analyses was designed. Standardized analyses may accelerate the development of scalable retinal imaging biomarkers for ADRD.
536 _ _ |a 354 - Disease Prevention and Healthy Aging (POF4-354)
|0 G:(DE-HGF)POF4-354
|c POF4-354
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Alzheimer's disease and related dementias
|2 Other
650 _ 7 |a accelerated cognitive ageing
|2 Other
650 _ 7 |a epidemiology
|2 Other
650 _ 7 |a harmonization
|2 Other
650 _ 7 |a imaging
|2 Other
650 _ 7 |a microvascular dysfunction
|2 Other
650 _ 7 |a neurodegenerative disease
|2 Other
650 _ 7 |a optical coherence tomography angiography
|2 Other
650 _ 7 |a population‐based study
|2 Other
650 _ 7 |a retinal imaging
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Tomography, Optical Coherence: methods
|2 MeSH
650 _ 2 |a Alzheimer Disease: diagnostic imaging
|2 MeSH
650 _ 2 |a Retinal Vessels: diagnostic imaging
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Fluorescein Angiography: methods
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Dementia: diagnostic imaging
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
693 _ _ |0 EXP:(DE-2719)Rhineland Study-20190321
|5 EXP:(DE-2719)Rhineland Study-20190321
|e Rhineland Study / Bonn
|x 0
700 1 _ |a Berendschot, Tos T J M
|b 1
700 1 _ |a Bonnin, Sophie
|b 2
700 1 _ |a Sobrin, Lucia
|b 3
700 1 _ |a De Jesus, Danilo Andrade
|b 4
700 1 _ |a Brea, Luisa Sanchez
|b 5
700 1 _ |a Martinez, Ana Collazo
|b 6
700 1 _ |a Raman, Rajiv
|b 7
700 1 _ |a de Vries, Victor A
|b 8
700 1 _ |a Huang, Haifan
|0 P:(DE-2719)9002740
|b 9
|u dzne
700 1 _ |a consortium, E3
|b 10
700 1 _ |a Study, for the Maastricht
|b 11
|e Collaboration Author
700 1 _ |a Study, Framingham Heart
|b 12
|e Collaboration Author
700 1 _ |a Study, Rotterdam
|b 13
|e Collaboration Author
700 1 _ |a Study, Rhineland
|b 14
|e Collaboration Author
700 1 _ |a Study, SIGNATR
|b 15
|e Collaboration Author
700 1 _ |a MacGillivray, Tom
|b 16
700 1 _ |a Ramdas, Wishal D
|b 17
700 1 _ |a van der Heide, Frank C T
|b 18
773 _ _ |a 10.1002/alz.70252
|g Vol. 21, no. 6, p. e70252
|0 PERI:(DE-600)2201940-6
|n 6
|p e70252
|t Alzheimer's and dementia
|v 21
|y 2025
|x 1552-5260
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/278997/files/DZNE-2025-00661.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/278997/files/DZNE-2025-00661.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:278997
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9002740
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-354
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Prevention and Healthy Aging
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-06
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-06
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-06
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-06
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-06
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-06
920 1 _ |0 I:(DE-2719)1012001
|k AG Breteler
|l Population Health Sciences
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1012001
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21